Supporting Evidence

1535 bookmarks
Newest
Disclosing drug companies payments should be compulsory, say top earners
Disclosing drug companies payments should be compulsory, say top earners
The doctors who declared the most earnings from drug companies in the United Kingdom’s new database have said that being transparent about payments should be mandatory. The database showed that 70% of healthcare professionals who received payments from drug companies agreed to have the information disclosed on Disclosure UK (www.disclosureuk.org.uk), which is hosted by the Association of the British Pharmaceutical Industry. But the 30% who didn’t agree to disclosure received more than half (52%) of the payments registered.1 From the data posted it is possible to find the top earners, but because of the way that the undeclared data are presented it is not possible to tell how they rank overall. Ian Pavord, …
·bmj.com·
Disclosing drug companies payments should be compulsory, say top earners
Safety Signals for COVID Vaccines Are Loud and Clear. Why Is Nobody Listening?
Safety Signals for COVID Vaccines Are Loud and Clear. Why Is Nobody Listening?
The public deserves a complete and transparent accounting of the Centers for Disease Control and Prevention’s safety monitoring, including the results of all interim reports and analyses, whether through a Freedom of Information Act request, Congressional order or some other means.
·childrenshealthdefense.org·
Safety Signals for COVID Vaccines Are Loud and Clear. Why Is Nobody Listening?
MHRA Approves Third COVID Antiviral Pill
MHRA Approves Third COVID Antiviral Pill
Pfizer's antiviral drug Paxlovid, which contains a combination of PF-07321332 and ritonavir, has been approved by the MHRA for use in those with mild to moderate COVID-19 at risk of developing more severe disease.
·medscape.co.uk·
MHRA Approves Third COVID Antiviral Pill
Under-Reporting of Adverse Drug Reactions
Under-Reporting of Adverse Drug Reactions
Drug Safety - The purpose of this review was to estimate the extent of under-reporting of adverse drug reactions (ADRs) to spontaneous reporting systems and to investigate whether there are...
·link.springer.com·
Under-Reporting of Adverse Drug Reactions
The novel coronavirus’ spike protein plays additional key role in illness - Salk Institute for Biological Studies
The novel coronavirus’ spike protein plays additional key role in illness - Salk Institute for Biological Studies
LA JOLLA—Scientists have known for a while that SARS-CoV-2’s distinctive “spike” proteins help the virus infect its host by latching on to healthy cells. Now, a major new study shows that the virus spike proteins (which behave very differently than those safely encoded by vaccines) also play a key role in the disease itself.
·salk.edu·
The novel coronavirus’ spike protein plays additional key role in illness - Salk Institute for Biological Studies
Pfizer Asks Court to Dismiss Whistleblower Lawsuit Because Government Was Aware of Fraud
Pfizer Asks Court to Dismiss Whistleblower Lawsuit Because Government Was Aware of Fraud
In an interview with The Defender, the lawyer representing whistleblower Brook Jackson said Pfizer is arguing the court should dismiss Jackson’s lawsuit alleging fraud in Pfizer’s COVID-19 clinical trials because the U.S. government knew about the wrongdoings but continued to do business with the vaccine maker.
·childrenshealthdefense.org·
Pfizer Asks Court to Dismiss Whistleblower Lawsuit Because Government Was Aware of Fraud
DR. JOHN IOANNIDIS
DR. JOHN IOANNIDIS
PERSPECTIVES ON THE PANDEMIC I (pt 1 & 2) A Conversation with Dr. John Ioannidis, Stanford University (Originally published March 23rd, 2020) PART ONE PART TWO JOHN KIRBY: So, professor, if you could just begin by telling us your name and a little bit about your background? DR. IOANNIDIS: I'm John Ioanniddis. I'm a professor of medicine and of epidemiology and population health at Stanford University. I'm one of the two directors, co-directors, of the Meta-research Innovation Center at Stanford
·thepressandthepublic.com·
DR. JOHN IOANNIDIS
Physicians Say Hospitals Are Pressuring ER Docs to List COVID-19 on Death Certificates. Here’s Why | Jon Miltimore
Physicians Say Hospitals Are Pressuring ER Docs to List COVID-19 on Death Certificates. Here’s Why | Jon Miltimore
Are hospitals conspiring to gin up COVID-19 deaths to make the pandemic look worse than it is? No. There’s a simpler explanation: incentives. As Minnesota lawmaker and longtime family practitioner Dr. Scott Jensen recently observed, hospitals are incentivized to pressure physicians to include COVID-19 on death certificates and discharge papers, since the CARES Act increases Medicare payments to hospitals treating COVID-19 victims.
·fee.org·
Physicians Say Hospitals Are Pressuring ER Docs to List COVID-19 on Death Certificates. Here’s Why | Jon Miltimore
THE INDOCTRINATED BRAIN WITH DR. MICHAEL NEHLS - The HighWire
THE INDOCTRINATED BRAIN WITH DR. MICHAEL NEHLS - The HighWire
Del sits down with physician and molecular geneticist, Dr. Michael Nehls to discuss his latest book, The Indoctrinated Brain, which delves into the intricacies of brain mechanisms, emphasizing the critical role of maintaining hippocampal health. This goes beyond safeguarding against diseases like Alzheimer’s; it extends to fortifying the mind against indoctrination. POSTED: January 12, 2024
·thehighwire.com·
THE INDOCTRINATED BRAIN WITH DR. MICHAEL NEHLS - The HighWire
The Case of Dr. Andrew Hill: Was there Unethical Activity Associated with his Ivermectin Meta-Analysis or Just Another Drug Dev Day?
The Case of Dr. Andrew Hill: Was there Unethical Activity Associated with his Ivermectin Meta-Analysis or Just Another Drug Dev Day?
By late last year with mounting numbers of ivermectin clinical trials, mostly from low-and middle-income countries (LMICs), the potential for ivermectin as a treatment for COVID-19 gained significant movement. Key studies from McMaster’s TOGETHER study to a meta-analysis authored by Dr. Andrew Hill, affiliated with the University of Liverpool, and Unitaid—affiliated organization of the World Health Organization (WHO)—were to pave the way for use of the low cost, repurposed drug. But due to a purported under-dosing in the TOGETHER study and some questionable last-minute changes in the Unitaid-sponsored Hill meta-analysis, the pro-ivermectin consensus went south. With pharmaceutical companies developing vaccines in support of a universal vaccination program, any low-cost alternatives for early care weren’t well supported by any influencers in the medical establishments of North America and Europe. Additional companies such as Gilead, Merck, AstraZeneca, Regeneron, and Pfizer were busy securing in the aggregate billions of taxpayer dollars to develop antivirals and monoclonal antibodies. The market for early-stage antiviral care for mild-to-moderate COVID-19 involves big stakes, and key industry players know it. The potential market could be worth $10 billion per year—clearly, blockbuster-plus territory. The vaccines could produce $100 billion in the first two years of the pandemic for Pfizer—just unprecedented amounts of money. Did a combination of well-intended vaccination and advanced therapy programs coupled with industry interests and regulatory capture lead to the sabotage of ivermectin initiatives? If true, does this implicate an entire drug development system that became painfully obvious during the first modern pandemic? If this is the case, then Andrew Hill becomes a poster child for bias, questionable ethics, and possibly even corruption at the highest levels. On the other hand, was it just a system working the way it has evolved to work?
·trialsitenews.com·
The Case of Dr. Andrew Hill: Was there Unethical Activity Associated with his Ivermectin Meta-Analysis or Just Another Drug Dev Day?